SIC: 2836 - BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
State location: P7 | State of Inc.: P7 | Fiscal Year End: 1231
formerly: QIAGEN NV (filings through 2020-02-14)
(CF Office: 03 Life Sciences)
Get insider transactions for this reporting owner.
| Filings | Format | Description | Filing Date | File/Film Number |
|---|---|---|---|---|
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-25-000015 (34 Act) Size: 495 KB |
2025-02-07 | 001-38332 25598692 |
| SCHEDULE 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0000902219-25-000015 (34 Act) Size: 16 KB |
2025-02-06 | 005-54659 25595758 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-25-000012 (34 Act) Size: 153 KB |
2025-01-16 | 001-38332 25536258 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-25-000008 (34 Act) Size: 147 KB |
2025-01-13 | 001-38332 25526268 |
| SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0000902219-24-000457 (34 Act) Size: 36 KB |
2024-11-08 | 005-54659 241438634 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000095 (34 Act) Size: 1 MB |
2024-11-08 | 001-38332 241437492 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000093 (34 Act) Size: 495 KB |
2024-11-08 | 001-38332 241437474 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000091 (34 Act) Size: 18 KB |
2024-11-08 | 001-38332 241437441 |
| SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0002012383-24-002629 (34 Act) Size: 14 KB |
2024-11-07 | 005-54659 241434112 |
| SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0002012383-24-000972 (34 Act) Size: 14 KB |
2024-10-21 | 005-54659 241383578 |
| 144 | Documents | Report of proposed sale of securities Acc-no: 0001972362-24-001325 (33 Act) Size: 6 KB |
2024-09-11 | 001-38332 241293496 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000080 (34 Act) Size: 217 KB |
2024-09-04 | 001-38332 241277926 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000078 (34 Act) Size: 221 KB |
2024-09-03 | 001-38332 241274281 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000074 (34 Act) Size: 1 MB |
2024-08-02 | 001-38332 241168616 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000072 (34 Act) Size: 658 KB |
2024-08-02 | 001-38332 241168599 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000069 (34 Act) Size: 135 MB |
2024-08-02 | 001-38332 241168584 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000054 (34 Act) Size: 35 MB |
2024-06-24 | 001-38332 241061829 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000047 (34 Act) Size: 156 KB |
2024-06-06 | 001-38332 241026163 |
| SD | Documents | Specialized disclosure report Acc-no: 0001015820-24-000043 (34 Act) Size: 43 KB |
2024-05-31 | 001-38332 241010428 |
| S-8 | Documents | Securities to be offered to employees in employee benefit plans Acc-no: 0001015820-24-000040 (33 Act) Size: 350 KB |
2024-05-30 | 333-279834 241006185 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000033 (34 Act) Size: 955 KB |
2024-05-01 | 001-38332 24899008 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000031 (34 Act) Size: 484 KB |
2024-05-01 | 001-38332 24898986 |
| IRANNOTICE | Documents | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Acc-no: 0001015820-24-000023 (34 Act) Size: 101 KB |
2024-03-11 | 001-38332 24736259 |
| 20-F | Documents Interactive Data | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Acc-no: 0001015820-24-000022 (34 Act) Size: 38 MB |
2024-03-11 | 001-38332 24736256 |
| SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0000912938-24-000212 (34 Act) Size: 17 KB |
2024-02-09 | 005-54659 24613268 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000008 (34 Act) Size: 618 KB |
2024-02-08 | 001-38332 24607154 |
| SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0001086364-24-001668 (34 Act) Size: 13 KB |
2024-01-23 | 005-54659 24552660 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000005 (34 Act) Size: 155 KB |
2024-01-23 | 001-38332 24550172 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-24-000002 (34 Act) Size: 151 KB |
2024-01-08 | 001-38332 24518747 |
| SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0000912938-23-000512 (34 Act) Size: 17 KB |
2023-12-06 | 005-54659 231468914 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-23-000053 (34 Act) Size: 1 MB |
2023-11-01 | 001-38332 231366168 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-23-000050 (34 Act) Size: 530 KB |
2023-11-01 | 001-38332 231366131 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-23-000048 (34 Act) Size: 12 MB |
2023-11-01 | 001-38332 231366103 |
| 144 | Documents | Report of proposed sale of securities Acc-no: 0001972362-23-000708 (33 Act) Size: 4 KB |
2023-08-25 | 001-38332 231209025 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-23-000038 (34 Act) Size: 1 MB |
2023-08-10 | 001-38332 231156998 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-23-000035 (34 Act) Size: 527 KB |
2023-08-10 | 001-38332 231156956 |
| SD | Documents | Specialized disclosure report Acc-no: 0001015820-23-000029 (34 Act) Size: 43 KB |
2023-05-30 | 001-38332 23971033 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-23-000026 (34 Act) Size: 1 MB |
2023-05-05 | 001-38332 23890948 |
| 6-K | Documents | Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001015820-23-000024 (34 Act) Size: 443 KB |
2023-05-05 | 001-38332 23890931 |
| IRANNOTICE | Documents | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Acc-no: 0001015820-23-000022 (34 Act) Size: 102 KB |
2023-05-05 | 001-38332 23890912 |